Skip to main content
Abbott India Ltd. logo

Abbott India Ltd. — Investor Relations & Filings

Ticker · ABBOTINDIA ISIN · INE358A01014 LEI · 5493008KZ9E3HFRN6T46 BSE.NS Manufacturing
Filings indexed 6 across all filing types
Latest filing 2026-05-13 Proxy Solicitation & In…
Country IN India
Listing BSE.NS ABBOTINDIA

About Abbott India Ltd.

https://www.abbott.co.in

Abbott India Ltd. is a pharmaceutical entity focused on providing high-quality healthcare solutions through a diverse portfolio of trusted brands. The company specializes in several key therapeutic areas, including women's health, gastroenterology, cardiology, metabolic disorders, primary care, and the central nervous system. Its product range features well-known formulations such as Duphaston, Thyronorm, Udiliv, Vertin, and Digene. The organization leverages advanced manufacturing capabilities and an extensive distribution network to serve healthcare professionals and patients. It emphasizes science-based innovation and clinical excellence to address evolving medical needs. By maintaining a strong focus on patient outcomes and therapeutic efficacy, the company has established itself as a reliable provider of pharmaceutical products across various specialized and general medical segments.

Recent filings

Filing Released Lang Actions
Newspaper Publication.
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal Postal Ballot Notice and explanatory statement sent to shareholders under Indian SEBI Listing Regulations and Companies Act provisions, providing full details of proposed resolutions and requesting remote e-voting. It is not the results announcement, not a financial report, but rather shareholder solicitation materials requesting votes. This aligns with a Proxy Solicitation & Information Statement (PSI).
2026-05-13 English
Newspaper publication.
Report Publication Announcement Classification · 78% confidence The document is addressed to BSE under SEBI LODR Regulation 47, notifying the exchange that newspaper cuttings of the audited quarterly and year-end financial results have been published and enclosing those cuttings (extracts of the audited results). It is not the full annual report or standalone interim report, nor merely management discussion—it is an announcement of the publication of the financial results. Under our “menu vs meal” rule and definitions, this is a Report Publication Announcement (RPA).
2026-05-13 English
Postal Ballot Notice - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal Postal Ballot Notice sent to shareholders under Section 110 of the Companies Act and SEBI Listing Regulations, providing explanatory statements, e-voting instructions, and requesting shareholder votes on resolutions for director appointments. It is not the actual poll results, an annual or interim report, nor an earnings release, but rather a solicitation of proxy votes. Therefore, it fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-13 English
Record Date for Dividend
Notice of Dividend Amount Classification · 95% confidence The document is an official notice to the stock exchange under SEBI Listing Regulations informing shareholders of the record date and payment date for the final dividend for the financial year ended March 31, 2026. It details dividend entitlement, record date (July 24, 2026), and payment timing. This matches the criteria for a Notice of Dividend Amount (code DIV).
2026-05-11 English
Audited Financial Results for the quarter and year ended March 31, 2026
Interim / Quarterly Report Classification · 92% confidence The document is a submission under SEBI Regulation 33 disclosing the audited financial results for the quarter and year ended March 31, 2026, including full statements (income, assets & liabilities, cash flows) and notes. This is more than an earnings highlight release and contains substantive financial data for a quarterly/periodic report outside of a full Annual Report. It matches the definition of an Interim / Quarterly Report under category IR, rather than a 10-K or simple earnings release. FY 2026
2026-05-11 English
Outcome of Board Meeting
Earnings Release Classification · 80% confidence The document is an official stock‐exchange filing under SEBI Listing Regulations detailing the ‘Outcome of Board Meeting’, including the Audited Financial Results for the quarter and full year ended March 31, 2026, the Statement of Assets & Liabilities, Cash Flows and dividend recommendation. It is not merely a notice of report publication, but the actual earnings release for the period. This matches the definition of an Earnings Release (initial announcement of periodical financial results). FY 2026
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.